Literature DB >> 19999808

[Hyperhomocysteinemia and the disturbance of haemostasis--facts and mythes].

Joanna Malinowska1, Paweł Nowak, Beata Olas.   

Abstract

The elevated concentration of homocysteine--Hcys (hyperhomocysteinemia) has been correlated with different pathologists, such as cardiovascular diseases. In the article, the some pathways of homocysteine metabolism (i.e. remethylation to methionine, formation of homocysteine thiolactone, and its enzymatic hydrolysis) and the actions of homocysteine and its metabolite--cyclic thioester--homocysteine thiolactone (HTL) on complex process of haemostasis, which regulates the flowing properties of blood, are described. Possible interaction of Hcys and HTL with endothelial cells, blood platelets, plasmatic fibrinogen and other coagulation factors, as the important major components of haemostasis are also discussed. The modification of haemostatic proteins (N-homocysteinylated or S-homocysteinylated proteins) induced by Hcys or its thiolactone, seem to be the main reason of biotoxicity of homocysteine in the disturbance of haemostasis and cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19999808

Source DB:  PubMed          Journal:  Pol Merkur Lekarski        ISSN: 1426-9686


  2 in total

Review 1.  The Potential of Dietary Bioactive Compounds against SARS-CoV-2 and COVID-19-Induced Endothelial Dysfunction.

Authors:  Jack N Losso
Journal:  Molecules       Date:  2022-03-01       Impact factor: 4.411

2.  Apoptosis of bone marrow mesenchymal stem cells caused by homocysteine via activating JNK signal.

Authors:  Benzhi Cai; Xingda Li; Yang Wang; Yanju Liu; Fan Yang; Hongyang Chen; Kun Yin; Xueying Tan; Jiuxin Zhu; Zhenwei Pan; Baoqiu Wang; Yanjie Lu
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.